About 181,000 results
Open links in new tab
  1. Innoviva – Healthcare Royalty and Asset Management

    Innoviva manages a respiratory royalty portfolio and makes strategic acquisitions in promising areas of unmet need, such as infectious diseases.

  2. Innoviva Inc (INVA) Stock Price & News - Google Finance

    Get the latest Innoviva Inc (INVA) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

  3. Innoviva, Inc. (INVA) Stock Price, News, Quote & History ...

    Find the latest Innoviva, Inc. (INVA) stock quote, history, news and other vital information to help you with your stock trading and investing.

  4. INVA Stock Price Quote | Morningstar

    3 days ago · See the latest Innoviva Inc stock price (INVA:XNAS), related news, valuation, dividends and more to help you make your investing decisions.

  5. INVA Stock Price | Innoviva Inc. Stock Quote (U.S.: Nasdaq ...

    Dec 8, 2025 · Innoviva, Inc. is engaged in the development, commercialization, and financial management of biopharmaceuticals.

  6. Innoviva (INVA) Stock Price & Overview

    4 days ago · A detailed overview of Innoviva, Inc. (INVA) stock, including real-time price, chart, key statistics, news, and more.

  7. Innoviva (INVA) Stock Price, News & Analysis - MarketBeat

    2 days ago · Innoviva, Inc., incorporated in Delaware and headquartered in San Francisco, California, is a royalty-focused life sciences company. It acquires, manages and monetizes …

  8. Innoviva - INVA - Stock Price Today - Zacks

    2 days ago · Get the latest Innoviva, Inc INVA detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.

  9. INVA: Innoviva Inc - Stock Price, Quote and News - CNBC

    Get Innoviva Inc (INVA:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.

  10. INVA - Innoviva Stock Price - Barchart.com

    Sep 23, 2025 · Innoviva, Inc. (NASDAQ: INVA) (“Innoviva” or the “Company”), a diversified holding company with a core royalties portfolio, a leading critical care and infectious disease …